Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 138

1.

Pycnogenol ameliorates depression-like behavior in repeated corticosterone-induced depression mice model.

Mei L, Mochizuki M, Hasegawa N.

Biomed Res Int. 2014;2014:942927. doi: 10.1155/2014/942927. Epub 2014 May 13.

2.

Comparison of depressive behaviors induced by three stress paradigms in rats.

Bai M, Zhang L, Zhu X, Zhang Y, Zhang S, Xue L.

Physiol Behav. 2014 May 28;131:81-6. doi: 10.1016/j.physbeh.2014.04.019. Epub 2014 Apr 18.

PMID:
24747276
3.

Acid-induced hyperalgesia and anxio-depressive comorbidity in rats.

Liu YT, Shao YW, Yen CT, Shaw FZ.

Physiol Behav. 2014 May 28;131:105-10. doi: 10.1016/j.physbeh.2014.03.030. Epub 2014 Apr 12.

PMID:
24726391
4.

Cardiac rehabilitation exercise and self-care for chronic heart failure.

Ades PA, Keteyian SJ, Balady GJ, Houston-Miller N, Kitzman DW, Mancini DM, Rich MW.

JACC Heart Fail. 2013 Dec;1(6):540-7. doi: 10.1016/j.jchf.2013.09.002. Epub 2013 Oct 24. Review.

5.

PPAR-α agonist fenofibrate protects against the damaging effects of MPTP in a rat model of Parkinson's disease.

Barbiero JK, Santiago R, Tonin FS, Boschen S, da Silva LM, Werner MF, da Cunha C, Lima MM, Vital MA.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Aug 4;53:35-44. doi: 10.1016/j.pnpbp.2014.02.009. Epub 2014 Mar 1.

PMID:
24593945
6.

Inherited behaviors, BDNF expression and response to treatment in a novel multifactorial rat model for depression.

Gersner R, Gal R, Levit O, Moshe H, Zangen A.

Int J Neuropsychopharmacol. 2014 Jun;17(6):945-55. doi: 10.1017/S1461145714000030. Epub 2014 Feb 11.

PMID:
24513109
7.

Reduction of physical activity in daily life and its determinants in smokers without airflow obstruction.

Furlanetto KC, Mantoani LC, Bisca G, Morita AA, Zabatiero J, Proença M, Kovelis D, Pitta F.

Respirology. 2014 Apr;19(3):369-75. doi: 10.1111/resp.12236. Epub 2014 Feb 2.

8.

Depression-like behaviors in mice subjected to co-treatment of high-fat diet and corticosterone are ameliorated by AICAR and exercise.

Liu W, Zhai X, Li H, Ji L.

J Affect Disord. 2014 Mar;156:171-7. doi: 10.1016/j.jad.2013.11.025. Epub 2013 Dec 17.

PMID:
24388462
9.

Behavioral impairments in rats with chronic epilepsy suggest comorbidity between epilepsy and attention deficit/hyperactivity disorder.

Pineda E, Jentsch JD, Shin D, Griesbach G, Sankar R, Mazarati A.

Epilepsy Behav. 2014 Feb;31:267-75. doi: 10.1016/j.yebeh.2013.10.004. Epub 2013 Nov 18.

10.

Ketamine reverses stress-induced depression-like behavior and increased GABA levels in the anterior cingulate: an 11.7 T 1H-MRS study in rats.

Perrine SA, Ghoddoussi F, Michaels MS, Sheikh IS, McKelvey G, Galloway MP.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jun 3;51:9-15. doi: 10.1016/j.pnpbp.2013.11.003. Epub 2013 Nov 15.

PMID:
24246571
11.

Lumbar surgery in work-related chronic low back pain: can a continuum of care enhance outcomes?

Mayer TG, Gatchel RJ, Brede E, Theodore BR.

Spine J. 2014 Feb 1;14(2):263-73. doi: 10.1016/j.spinee.2013.10.041. Epub 2013 Nov 12.

12.

Association between physical activity and major depressive disorder among current or former smokers with pulmonary disease.

Loprinzi PD, Kane C, Walker JF.

Prev Med. 2013 Nov;57(5):545-9. doi: 10.1016/j.ypmed.2013.07.009. Epub 2013 Jul 16.

PMID:
23867715
13.

The relationship of chronic medical illnesses, poor health-related lifestyle choices, and health care utilization to recovery status in borderline patients over a decade of prospective follow-up.

Keuroghlian AS, Frankenburg FR, Zanarini MC.

J Psychiatr Res. 2013 Oct;47(10):1499-506. doi: 10.1016/j.jpsychires.2013.06.012. Epub 2013 Jul 12.

14.

Exercise training and depression in ESRD: a review.

Mitrou GI, Grigoriou SS, Konstantopoulou E, Theofilou P, Giannaki CD, Stefanidis I, Karatzaferi C, Sakkas GK.

Semin Dial. 2013 Sep-Oct;26(5):604-13. doi: 10.1111/sdi.12112. Epub 2013 Jul 9. Review.

PMID:
23834201
15.

Magnolol treatment reversed the glial pathology in an unpredictable chronic mild stress-induced rat model of depression.

Li LF, Yang J, Ma SP, Qu R.

Eur J Pharmacol. 2013 Jul 5;711(1-3):42-9. doi: 10.1016/j.ejphar.2013.04.008. Epub 2013 Apr 28.

PMID:
23632393
16.

Painful effects of auditory startle, forehead cooling and psychological stress in patients with fibromyalgia or rheumatoid arthritis.

Drummond PD, Willox M.

J Psychosom Res. 2013 May;74(5):378-83. doi: 10.1016/j.jpsychores.2013.01.011. Epub 2013 Feb 17.

PMID:
23597324
17.

Further evaluation of the neuropharmacological determinants of the antidepressant-like effects of curcumin.

Witkin JM, Leucke S, Thompson LK, Lynch RA, Ding C, Heinz B, Catlow JT, Gleason SD, Li X.

CNS Neurol Disord Drug Targets. 2013 Jun;12(4):498-505.

PMID:
23574162
18.

Effect of an mGlu2/3 receptor antagonist on depressive behavior induced by withdrawal from chronic treatment with methamphetamine.

Iijima M, Koike H, Chaki S.

Behav Brain Res. 2013 Jun 1;246:24-8. doi: 10.1016/j.bbr.2013.02.039. Epub 2013 Mar 5.

PMID:
23473878
19.

Protein kinase C regulates mood-related behaviors and adult hippocampal cell proliferation in rats.

Abrial E, Etievant A, Bétry C, Scarna H, Lucas G, Haddjeri N, Lambás-Señas L.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jun 3;43:40-8. doi: 10.1016/j.pnpbp.2012.11.015. Epub 2012 Dec 8.

PMID:
23228462
20.

Metabonomics approach to assessing the modulatory effects of St John's wort, ginsenosides, and clomipramine in experimental depression.

Wang X, Zeng C, Lin J, Chen T, Zhao T, Jia Z, Xie X, Qiu Y, Su M, Jiang T, Zhou M, Zhao A, Jia W.

J Proteome Res. 2012 Dec 7;11(12):6223-30. doi: 10.1021/pr300891v. Epub 2012 Nov 13.

PMID:
23110693
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk